Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bausch Health Americas, Inc.
With
Dow Pharmaceutical Sciences
The primary objective of this study is to compare the efficacy and safety and tolerability of ACYC Gel and vehicle in the treatment of subjects with Acne Vulgaris
Age
12–40
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female between the ages of 12 and 40 (inclusive)
Written and verbal informed consent must be obtained.
Subjects less than 18 years of age must sign an assent for the study and a parent or a legal guardian must sign the informed consent
Subject must have moderate to severe acne at the baseline visit
Women of childbearing potential must be willing to practice effective contraception for the duration of the study
You may not be if
Use of an investigational drug or device within 30 days of enrollment or participation in a research study concurrent with this study
Dermatological conditions on the face that could interfere with clinical evaluations
Clareo Health | Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne
